72
Views
2
CrossRef citations to date
0
Altmetric
Letter

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al

, , , , &
Pages 157-159 | Published online: 19 Aug 2016
 
This article responds to:
Triple-negative breast cancer: treatment challenges and solutions

Disclosure

The authors report no conflicts of interest in this communication.

Disclosure

GJ has received honoraria from Amgen, Pfizer, Novartis, Roche, and Celgene and research grants from Novartis, Roche, and MSD. The authors report no other conflicts of interest in this communication.